These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
241 related articles for article (PubMed ID: 33312891)
1. Lenvatinib as first-line therapy for recurrent hepatocellular carcinoma after liver transplantation: Is the current evidence applicable to these patients? Piñero F; Thompson M; Marín JI; Silva M World J Transplant; 2020 Nov; 10(11):297-306. PubMed ID: 33312891 [TBL] [Abstract][Full Text] [Related]
2. Systemic Treatment of Recurrent Hepatocellular Carcinoma after Liver Transplantation: A Multicenter Trial. Himmelsbach V; Jeschke M; Lange CM; Scheiner B; Pinter M; Sinner F; Venerito M; Queck A; Trojan J; Waidmann O; Finkelmeier F Cancers (Basel); 2024 Jul; 16(13):. PubMed ID: 39001504 [TBL] [Abstract][Full Text] [Related]
3. Efficacy and Safety of Lenvatinib in Hepatocellular Carcinoma Patients with Liver Transplantation: A Case-Control Study. Chen YY; Chen CL; Lin CC; Wang CC; Liu YW; Li WF; Chen YH Cancers (Basel); 2021 Sep; 13(18):. PubMed ID: 34572811 [TBL] [Abstract][Full Text] [Related]
4. A Comparison of Lenvatinib versus Sorafenib in the First-Line Treatment of Unresectable Hepatocellular Carcinoma: Selection Criteria to Guide Physician's Choice in a New Therapeutic Scenario. Dipasquale A; Marinello A; Santoro A J Hepatocell Carcinoma; 2021; 8():241-251. PubMed ID: 33884259 [TBL] [Abstract][Full Text] [Related]
5. Systemic Therapy for Advanced Hepatocellular Carcinoma: An Update of a Rapidly Evolving Field. Doycheva I; Thuluvath PJ J Clin Exp Hepatol; 2019; 9(5):588-596. PubMed ID: 31695249 [TBL] [Abstract][Full Text] [Related]
6. Prophylactic liver transplantation for high-risk recurrent hepatocellular carcinoma. Yang PC; Ho CM; Hu RH; Ho MC; Wu YM; Lee PH World J Hepatol; 2016 Nov; 8(31):1309-1317. PubMed ID: 27872682 [TBL] [Abstract][Full Text] [Related]
7. New Systemic Treatments in Advanced Hepatocellular Carcinoma. Sanduzzi-Zamparelli M; Díaz-Gonzalez Á; Reig M Liver Transpl; 2019 Feb; 25(2):311-322. PubMed ID: 30317696 [TBL] [Abstract][Full Text] [Related]
8. Assessing Competing Risks for Death Following Liver Transplantation for Hepatocellular Carcinoma. Sposito C; Cucchetti A; Mazzaferro V Dig Dis Sci; 2019 Apr; 64(4):1001-1007. PubMed ID: 30852770 [TBL] [Abstract][Full Text] [Related]
9. Treatment of recurrent hepatocellular carcinoma after liver transplantation. Kim HR; Cheon SH; Rha SY; Lee S; Han KH; Chon CY; Lee JD; Sung JS; Chung HC Asia Pac J Clin Oncol; 2011 Sep; 7(3):258-69. PubMed ID: 21884437 [TBL] [Abstract][Full Text] [Related]
10. Potential Role of Adjuvant Lenvatinib in Improving Disease-Free Survival for Patients With High-Risk Hepatitis B Virus-Related Hepatocellular Carcinoma Following Liver Transplantation: A Retrospective, Case Control Study. Han B; Ding H; Zhao S; Zhang Y; Wang J; Zhang Y; Gu J Front Oncol; 2020; 10():562103. PubMed ID: 33365268 [TBL] [Abstract][Full Text] [Related]
11. Current and Future Systemic Therapies for Hepatocellular Carcinoma. Bteich F; Di Bisceglie AM Gastroenterol Hepatol (N Y); 2019 May; 15(5):266-272. PubMed ID: 31360140 [TBL] [Abstract][Full Text] [Related]
12. Sequencing of systemic treatment for hepatocellular carcinoma: Second line competitors. Piñero F; Silva M; Iavarone M World J Gastroenterol; 2020 Apr; 26(16):1888-1900. PubMed ID: 32390700 [TBL] [Abstract][Full Text] [Related]
13. Hepatocellular Carcinoma: The Evolving Role of Systemic Therapies as a Bridging Treatment to Liver Transplantation. Saleh Y; Abu Hejleh T; Abdelrahim M; Shamseddine A; Chehade L; Alawabdeh T; Mohamad I; Sammour M; Turfa R Cancers (Basel); 2024 May; 16(11):. PubMed ID: 38893200 [TBL] [Abstract][Full Text] [Related]
14. Liver resection as a bridge to transplantation for hepatocellular carcinoma on cirrhosis: a reasonable strategy? Adam R; Azoulay D; Castaing D; Eshkenazy R; Pascal G; Hashizume K; Samuel D; Bismuth H Ann Surg; 2003 Oct; 238(4):508-18; discussion 518-9. PubMed ID: 14530722 [TBL] [Abstract][Full Text] [Related]